-Gregory M Lanza Researcher Activity Profile

Research Author Detailed Information 

Gregory M Lanza Publication Rate By Year

Gregory M Lanza has published 1 paper(s) in 2005, 1 paper(s) in 2006, 10 paper(s) in 2007, 3 paper(s) in 2008, for a total of 15 research publications in total.

Gregory M Gm Lanza Author Information

LAST NAME: lanza

FIRST NAME: Gregory M

INITIALS: gm

AFFILIATION:

Papers

Gregory M Lanza's Publication Record

1. (1)H/(19)F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. Year Published: 2005
Division of Cardiology, Washington University Medical School, St. Louis Missouri 63110; Division of Bioengineering, Washington University Medical School, St. Louis Missouri 63110.
2. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin. Year Published: 2006
Department of Medicine, Cardiovascular Division, Washington University, St. Louis, Missouri 63108, USA. patrick@cvu.wustl.edu
3. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles. Year Published: 2007
Medicine and Biomedical Engineering, C-TRAIN Group, St. Louis, MO 63108, USA. patrick@cvu.wustl.edu
4. Molecular imaging and therapy of atherosclerosis with targeted nanoparticles. Year Published: 2007
Department of Medicine, Washington University, St. Louis, Missouri 63110, USA. saw@wuphys.wustl.edu
5. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. Year Published: 2007
Department of Medicine, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO 63110, USA.
6. Properties of an entropy-based signal receiver with an application to ultrasonic molecular imaging. Year Published: 2007
School of Medicine, Washington University, St. Louis, Missouri 63108, USA. msh@cvu.wustl.edu
7. Sensitive ultrasonic detection of dystrophic skeletal muscle in patients with duchenne muscular dystrophy using an entropy-based signal receiver. Year Published: 2007
Washington University, School of Medicine, St Louis, MO 63108, USA. msh@cvu.wust.edu
8. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. Year Published: 2007
Washington University School of Medicine, Cardiovascular Division, St Louis, MO 63108, USA. jnm@cvu.wustl.edu
9. Sensitive ultrasonic delineation of steroid treatment in living dystrophic mice with energy-based and entropy-based radio frequency signal processing. Year Published: 2007
Washington University School of Medicine, Washington University, St. Louis, MO, USA. kirk.wallace@wustl.edu
10. Molecular Imaging by Cardiovascular MR. Year Published: 2007
Division of Cardiology, Washington University School of Medicine, St. Louis, Missouri, USA.
11. Molecular imaging by cardiovascular MR. Year Published: 2007
Division of Cardiology, Washington University School of Medicine, St. Louis, MO 63108, USA.
12. Sensitive ultrasonic delineation of steroid treatment in living dystrophic mice with energy-based and entropy-based radio frequency signal processing. Year Published: 2007
Washington University School of Medicine, Washington University, St. Louis, MO, USA. kirk.wallace@wustl.edu
13. Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Year Published: 2008
Division of Cardiology, Washington University Medical School, 660 South Euclid Blvd, St Louis, Missouri 63110, USA.
14. Experimental determination of phase velocity of perfluorocarbons: Applications to targeted contrast agents. Year Published: 2008
Dept. of Cardiol., Washington Univ. Sch. of Med., St. Louis, MO.
15. Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Year Published: 2008
Division of Cardiology, Washington University Medical School, 660 South Euclid Blvd, St Louis, Missouri 63110, USA.